These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 278641)

  • 1. Acute leukemia after prolonged immunosuppressive therapy for glomerulonephritis.
    Carcassonne Y; Gastaut JA; Blanc AP
    Cancer Treat Rep; 1978 Jul; 62(7):1110-1. PubMed ID: 278641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute leukemia secondary to the treatment of multiple sclerosis with chlorambucil].
    Aymard JP; Witz F; Conroy T; Lederlin P; Humbert JC; Barroche G; Streiff F
    Rev Neurol (Paris); 1985; 141(2):152-4. PubMed ID: 3858929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukaemia during immunosuppressive therapy of glomerulonephritis.
    Uszyński L; Szczecińska M; Dudkiewicz H; Sliwowski A
    Mater Med Pol; 1978; 10(3):226-7. PubMed ID: 281591
    [No Abstract]   [Full Text] [Related]  

  • 4. [A particular risk of prolonged immunosuppressive treatment: a case of acute myelomonocytic leukemia after chlorambucil treatment of severe rheumatoid arhtritis].
    Cazalis P; Caroit M; Zittoun R; Kahn MF; Sèze S
    Rev Rhum Mal Osteoartic; 1976 Jun; 43(6):431-5. PubMed ID: 781790
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute leukaemia during immunosuppressive treatment. One case (author's transl)].
    Blanc AP; Gastaut JA; Sébahoun G; Dalivoust P; Murisasco A; Carcassonne Y
    Nouv Presse Med; 1981 May; 10(21):1717-9. PubMed ID: 6940102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorambucil-induced acute hepatic failure in a patient with membranous nephropathy.
    Patel SP; Nast CC; Adler SG
    Am J Kidney Dis; 2000 Aug; 36(2):401-4. PubMed ID: 10922320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents.
    Sotrel G; Jafari K; Lash AF; Stepto RC
    Obstet Gynecol; 1976 Jan; 47(1):67S-71S. PubMed ID: 1061006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute granulous leukemia in multiple myeloma. Apropos of 5 cases].
    Krulik M; Grolleau JY; Audebert AA; Mougeot-Martin M; Harousseau JL; Hervouet D; Debray J
    Sem Hop; 1977 Dec; 53(42):2425-35. PubMed ID: 203043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alkylating agents in membranous nephropathy: efficacy proven beyond doubt.
    Hofstra JM; Wetzels JF
    Nephrol Dial Transplant; 2010 Jun; 25(6):1760-6. PubMed ID: 20133280
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute myeloid leukemia and other myelopathic disorders following treatment with alkylating agents.
    Bennett JM; Moloney WC; Greene MH; Boice JD
    Hematol Pathol; 1987; 1(2):99-104. PubMed ID: 3504435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].
    Lagrue G; Bariety J
    Minerva Med; 1970 Jul; 61(55):3054-63. PubMed ID: 5427678
    [No Abstract]   [Full Text] [Related]  

  • 12. Occurrence of second tumors in man after anticancer drug treatment.
    Schmähl D; Habs M; Lorenz M; Wagner I
    Cancer Treat Rev; 1982 Sep; 9(3):167-94. PubMed ID: 7159878
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of 2-year use of the immunosuppressive drugs dipyridamole and methindol in the treatment of patients with chronic mesangiocapillary glomerulonephritis].
    Kacprzyk F; Kubala L; Chrzanowski W; Pastuszko-Maryniarczyk T
    Pol Tyg Lek; 1987 Aug; 42(34):1046-9. PubMed ID: 3422838
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myeloid leukemia following non-Hodgkin's lymphoma: danger of prolonged use of chlorambucil as maintenance therapy.
    Dumont J; Thiery JP; Mazabraud A; Natali JC; Trapet P; Vilcoq JR
    Nouv Rev Fr Hematol (1978); 1980; 22(4):391-404. PubMed ID: 6942388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance].
    Kahn MF; De Seze S
    Ann Med Interne (Paris); 1974; 125(6-7):497-506. PubMed ID: 4216281
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications for immunosuppressive treatment in kidney diseases of children].
    Wojnarowski M; Wyszyńska T
    Pediatr Pol; 1969 May; 44(5):525-30. PubMed ID: 4183009
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs.
    Cardamone JM; Kimmerle RI; Marshall EY
    Am J Med; 1974 Nov; 57(5):836-42. PubMed ID: 4216270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiprolifirative effect of chlorbutin and sensitivity of patients with glomerulonephritis to this drug].
    Pukhal'skiĭ AL; Toptygina AP; Dolomanova OE; Naumova VI; Torubarova NA
    Pediatriia; 1991; (4):39-43. PubMed ID: 2067910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of nephrosis in the child].
    Loirat C; Baudouin V; Cloarec S; Peuchmaur M
    Arch Pediatr; 1998; 5 Suppl 2():142s-149s. PubMed ID: 9759242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Indications and effectiveness of combined therapy in chronic glomerulonephritis].
    Ratner MIa; Biriukova LS; Makurov AI
    Ter Arkh; 1987; 59(8):29-34. PubMed ID: 3686442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.